FDA Inspection 1051834 — Peter Kranke
The FDA completed an inspection of Peter Kranke on Apr 19, 2018 in Wurzburg. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 19, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Wurzburg (Germany)
Additional Details
Clinical Investigator (CI)